316 related articles for article (PubMed ID: 8798258)
21. Treatment of airway inflammation in cystic fibrosis.
Konstan MW
Curr Opin Pulm Med; 1996 Nov; 2(6):452-6. PubMed ID: 9363184
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis.
Martin SL; Downey D; Bilton D; Keogan MT; Edgar J; Elborn JS;
Pediatr Pulmonol; 2006 Feb; 41(2):177-83. PubMed ID: 16372352
[TBL] [Abstract][Full Text] [Related]
23. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis.
Renner S; Rath R; Rust P; Lehr S; Frischer T; Elmadfa I; Eichler I
Thorax; 2001 Jan; 56(1):48-52. PubMed ID: 11120904
[TBL] [Abstract][Full Text] [Related]
24. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function.
Wood LG; Fitzgerald DA; Lee AK; Garg ML
Am J Clin Nutr; 2003 Jan; 77(1):150-9. PubMed ID: 12499335
[TBL] [Abstract][Full Text] [Related]
25. [Plasma concentration of polymorphonuclear leukocyte elastase-alpha 1-proteinase inhibitor complex in patients with gastric ulcer].
Okajima K; Oyama H; Kimura K; Maeda K; Obata S; Ogata Y; Okabe H; Koga S; Takatsuki K
Rinsho Byori; 1990 Aug; 38(8):901-5. PubMed ID: 2232251
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G
Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872
[TBL] [Abstract][Full Text] [Related]
27. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis.
Meyer KC; Zimmerman J
J Lab Clin Med; 1993 May; 121(5):654-61. PubMed ID: 8386737
[TBL] [Abstract][Full Text] [Related]
28. Antioxidant effect of beta-carotene in cystic fibrosis and bronchiectasis: clinical and laboratory parameters of a pilot study.
Cobanoğlu N; Ozçelik U; Göçmen A; Kiper N; Doğru D
Acta Paediatr; 2002; 91(7):793-8. PubMed ID: 12200905
[TBL] [Abstract][Full Text] [Related]
29. Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis.
Suter S; Schaad UB; Roux-Lombard P; Girardin E; Grau G; Dayer JM
Am Rev Respir Dis; 1989 Dec; 140(6):1640-4. PubMed ID: 2604293
[TBL] [Abstract][Full Text] [Related]
30. alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis.
O'Connor CM; Gaffney K; Keane J; Southey A; Byrne N; O'Mahoney S; Fitzgerald MX
Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1665-70. PubMed ID: 8256917
[TBL] [Abstract][Full Text] [Related]
31. Effects of alpha-tocopherol and beta-carotene on hepatic lipid peroxidation and blood lipids in rats with dietary iron overload.
Whittaker P; Wamer WG; Chanderbhan RF; Dunkel VC
Nutr Cancer; 1996; 25(2):119-28. PubMed ID: 8710681
[TBL] [Abstract][Full Text] [Related]
32. Free radical activity and lipid soluble anti-oxidant vitamin status in patients with long-term ileal pouch-anal anastomosis.
El Muhtaseb MS; Talwar D; Duncan A; St J O'reilly D; McKee RF; Anderson JH; Foulis A; Finlay IG
Colorectal Dis; 2009 Jan; 11(1):67-72. PubMed ID: 18400037
[TBL] [Abstract][Full Text] [Related]
33. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.
Ogushi F; Fells GA; Hubbard RC; Straus SD; Crystal RG
J Clin Invest; 1987 Nov; 80(5):1366-74. PubMed ID: 3500183
[TBL] [Abstract][Full Text] [Related]
34. Plasma concentrations of micronutrients during a nine-month clinical trial of beta-carotene in women with precursor cervical cancer lesions.
Palan PR; Chang CJ; Mikhail MS; Ho GY; Basu J; Romney SL
Nutr Cancer; 1998; 30(1):46-52. PubMed ID: 9507512
[TBL] [Abstract][Full Text] [Related]
35. [An alpha 1-antitrypsin aerosol in the treatment of cystic fibrosis].
Ferrer Calvete J; Aznar Lucea J; Morales Marín P; Pereda Pérez A; Llopis Carles R; Ribes Koninckx C; Ferrer González P; Marco Martínez V
An Esp Pediatr; 1996 Feb; 44(2):109-11. PubMed ID: 8830566
[TBL] [Abstract][Full Text] [Related]
36. Response to oral beta-carotene supplementation in patients with cystic fibrosis: a 16-month follow-up study.
Winklhofer-Roob BM; van't Hof MA; Shmerling DH
Acta Paediatr; 1995 Oct; 84(10):1132-6. PubMed ID: 8563224
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil recruitment into the lungs is associated with increased lung elastase burden, decreased lung elastin, and emphysema in alpha 1 proteinase inhibitor-deficient mice.
Cavarra E; Martorana PA; Gambelli F; de Santi M; van Even P; Lungarella G
Lab Invest; 1996 Aug; 75(2):273-80. PubMed ID: 8765327
[TBL] [Abstract][Full Text] [Related]
38. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
[TBL] [Abstract][Full Text] [Related]
39. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
McElvaney NG; Nakamura H; Birrer P; Hébert CA; Wong WL; Alphonso M; Baker JB; Catalano MA; Crystal RG
J Clin Invest; 1992 Oct; 90(4):1296-301. PubMed ID: 1357002
[TBL] [Abstract][Full Text] [Related]
40. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
Goldstein W; Döring G
Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
